Latest News
Why Shares of BioNTech Rose Friday
The company released positive trial data for a non-small cell lung cancer therapy.
Why Pfizer Stock Slipped by 2% Today
The market wasn't impressed by the company's latest drug approval, plus an analyst cut her price target on the shares.
2 Undervalued Stocks to Buy for Potentially Massive Gains in the Next 10 Years
Both are experiencing a bit of a hangover from declining COVID-19-related sales.
BioNTech Se (BNTX) Q1 2023 Earnings Call Transcript
BNTX earnings call for the period ending March 31, 2023.
Arbutus is seeking damages, including reasonable royalties, over the use of lipid nanoparticle delivery technology in Pfizer-BioNTech vaccines to carry and deliver genetic material into the body
Why Shares of BioNTech Slumped Monday
The company released fourth-quarter earnings.
What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is up +0.26%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.13%. U.S. stock indexes this morning are mixed. The broader...
BioNTech had a strong quarter and may become a takeover target due to its healthy pipeline and a looming patent cliff for big pharma.
Could CRISPR Therapeutics Become the Next Moderna?
Both companies use cutting-edge technology.
First Quarter Ends with Canadian Payroll Numbers
Monday U.S. Featured EarningsBioNTech SE (NASDAQ: BNTX) (Q4) Reported EPS of $8.68, compared ...